<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>11</Volume><Issue>2</Issue></Journal><ArticleTitle>Syntheses and Anticonvulsant Activity of N4-Substituted Triazolylthiazoles</ArticleTitle><FirstPage>74</FirstPage><LastPage>78</LastPage><AuthorList><Author><FirstName></FirstName><LastName>Maria Bineshmarvasti</LastName></Author><Author><FirstName></FirstName><LastName>Mohammad Sharifzadeh</LastName></Author><Author><FirstName></FirstName><LastName>Amir Reza Jalilian</LastName></Author><Author><FirstName></FirstName><LastName>Kambiz Soltaninejad  Abbas Shafiee</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>06</Day></PubDate></History><Abstract>Due to the good anticonvulsant activity of various 1,2,4-triazoles, several new N4-substituted triazolylthiazoles were prepared by the general method for 1,2,4-triazole ring closure. Anticonvulsant activity of compounds was measured against pentylenetetrazole-induced seizures in mice by intraperitoneal injections of different doses of the test compounds. Pretreatment of animals with flumazenil (10 mg/kg, i.p.) as a benzodiazepine receptors antagonist did not have any significant effect on anticonvulsant activity of the test compounds. These results demonstrate that the anticonvulsant activity of N4-substituted triazolylthiazole agents is not probably mediated by direct interaction with benzodiazepine receptor complex.</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/173</web_url><pdf_url>https://daru.tums.ac.ir/index.php/daru/article/download/173/173</pdf_url></Article></Articles>
